Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Carvedilol: something else than a simple betablocker?

A Palazzuoli1, P Calabria, M S Verzuri

  • 1Institute of Clinical and Experimental Medicine, University of Siena.

European Review for Medical and Pharmacological Sciences
|June 5, 2003
PubMed
Summary

Carvedilol, a beta-blocker with vasodilatative effects, offers cardiovascular benefits including improved hemodynamics and anti-ischemic properties. Recent trials highlight its favorable impact on heart failure treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Current therapeutic strategies in cardiorenal syndrome.

Minerva cardioangiologica·2012
Same author

Clinical impact of BNP and other emerging biomarkers in heart failure evaluation and management.

Minerva cardioangiologica·2012
Same author

Genetic influence in statin intolerance.

Clinical pharmacology and therapeutics·2011
Same author

Cranial osteolytic metastases as the only recurrence of gastric carcinoma.

European review for medical and pharmacological sciences·2011
Same author

Bosentan treatment for Raynauds phenomenon and skin fibrosis in patients with Systemic Sclerosis and pulmonary arterial hypertension: an open-label, observational, retrospective study.

International journal of immunopathology and pharmacology·2011
Same author

Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure.

Vascular health and risk management·2010

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine
  • Clinical Therapeutics

Background:

  • Carvedilol is a cardiovascular drug with beta-blocker and vasodilatative properties.
  • Its multifaceted actions benefit the cardiovascular system through various mechanisms.

Purpose of the Study:

  • To review the beneficial properties of carvedilol.
  • To analyze the rational clinical use of carvedilol, particularly in heart failure.

Main Methods:

  • Literature review of carvedilol's properties and clinical applications.
  • Analysis of recent clinical trials focusing on heart failure.

Main Results:

  • Carvedilol demonstrates hemodynamic, anti-ischemic, antiproliferative, and antiarrhythmic benefits.

Related Experiment Videos

  • Antioxidant, neurohumoral, and electrophysiological effects contribute to its therapeutic value.
  • Evidence supports carvedilol's favorable effect in treating heart failure.

    • Conclusions:

    • Carvedilol is effective in treating hypertension, coronary heart disease, and congestive heart failure.
    • Recent evidence strongly supports its use in heart failure management.